Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2005 Feb;29(2):245-8.
doi: 10.1007/s00268-004-7456-7.

Transmetatarsal amputation: three-year experience at Groote Schuur Hospital

Affiliations
Comparative Study

Transmetatarsal amputation: three-year experience at Groote Schuur Hospital

B P Mwipatayi et al. World J Surg. 2005 Feb.

Abstract

Transmetatarsal amputation (TMA) for peripheral vascular disease has the reputation of being an operation with a poor outcome. This retrospective study reviewed a 3-year consecutive series of TMA in diabetic and nondiabetic patients. All amputations performed for peripheral vascular disease at Groote Schuur Hospital from January 1999 to December 2002 were reviewed. Data were obtained from hospital records and operating theatre books. The following groups were defined for the purpose of this retrospective study: group 1, TMAs performed in diabetic patients; group 2, TMAs done in nondiabetic patients. Altogether, 43 TMAs were performed: 27 in group 1 and 16 in group 2. Perioperative mortality rates were 7% and 4%, respectively. Overall, the healing rate was 67%: 62% (17/27) in group 1 and 75% (12/16) in group 2. The median times to healing were 8 months in group 1 and 7 months in group 2. Toe pressure and the presence of advanced tibioperoneal disease influenced the outcome of TMA in diabetic patients. Transmetatarsal amputation with a healed stump provided our patients with good mobility. Prediction of healing after operation is unreliable. There was no statistical difference in outcome in diabetic (group 1) versus nondiabetic (group 2) patients.

PubMed Disclaimer

References

    1. Aust N Z J Surg. 1995 May;65(5):339-41 - PubMed
    1. Br J Surg. 1992 Aug;79(8):753-5 - PubMed
    1. J Vasc Surg. 1991 May;13(5):705-11 - PubMed
    1. J Vasc Surg. 1994 Feb;19(2):341-8; discussion 348-9 - PubMed
    1. Ann Surg. 1949 Oct;130(4):826-42 - PubMed

Publication types

LinkOut - more resources